Larson Financial Group’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
Other funds holding CRBU
KCM
Larson Financial Group's CRBU Position: Q3 2026 in Review
Larson Financial Group held its Caribou Biosciences (CRBU) position steady in Q3 2026 at 11 shares worth $14. The position accounts for ﹤0.01% of the portfolio, ranked #3824.
Larson Financial Group first reported a position in CRBU in Q4 2025 and has held it in 4 quarters since. The position peaked at $7.72K in Q1 2026. 147 funds tracked by Wall St. Rank hold CRBU as of Q3 2026.
- Larson Financial Group held 11 shares of Caribou Biosciences worth $14 as of Q3 2026.
- Larson Financial Group left its Caribou Biosciences share count unchanged in Q3 2026.
- Caribou Biosciences made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3824 holding.
- Larson Financial Group first reported a position in Caribou Biosciences in Q4 2025 and has held it in 4 quarters since.
- Larson Financial Group's Caribou Biosciences position peaked at $7.72K in Q1 2026.
- 147 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.